Crystallographic Analysis Reveals that Anticancer Clinical Candidate L-778,123 Inhibits Protein Farnesyltransferase and Geranylgeranyltransferase-I by Different Binding Modes
Year: 2004
Type: article
Source: Biochemistry
DOI: 10.1021/bi049280b
Authors: T. Scott Reid, Stephen B. Long, Lorena S. Beese
Institution: Duke Medical Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Awards: G2457680162, G4036938481
OpenAlex ID: W2016552910
